Search research articles
Contact Us
Filters
Showing results (31-40 of 144) with videos related to
Page
of 15
Sort By:
Onkologie
|
February 5, 2003
Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin
M Joerger, C Oehlschlegel, T Cerny, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 12, 1998
Comparative pharmacokinetics of oral and intravenous ifosfamide/mesna/methylene blue therapy
C Aeschlimann, A Küpfer, H Schefer, et al.
Palliative Medicine
|
March 9, 2007
Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods study
F Strasser, J Binswanger, T Cerny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2008
Remission of diabetes while on sunitinib treatment for renal cell carcinoma
A Templeton, M Brändle, T Cerny, et al.
Schweizerische Medizinische Wochenschrift
|
March 18, 1995
[Diagnosis and therapy of multiple myeloma: current aspects]
D C Betticher, T Cerny, M F Fey
Current Drug Targets
|
October 21, 2009
The role of pemetrexed in advanced non small-cell lung cancer: special focus on pharmacology and mechanism of action
M Joerger, A Omlin, T Cerny, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1991
Metabolism and pharmacokinetics of oral and intravenous ifosfamide
V Kurowski, T Cerny, A Küpfer, et al.
Seminars in Oncology
|
February 1, 1992
Novel approaches with ifosfamide in small cell lung cancer
N Thatcher, M Lind, E De Campos, et al.
Schweizerische Medizinische Wochenschrift
|
September 15, 1990
[Preventive and therapeutic measures in cytostatic-associated toxicity]
T Cerny, K Buser, J Kiser, et al.
British Journal of Cancer
|
April 1, 1986
Genetic predisposition to human lung cancer
J Heighway, N Thatcher, T Cerny, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 144) with videos related to
Sort By:
Page
of 15
Onkologie
|
February 5, 2003
Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin
M Joerger, C Oehlschlegel, T Cerny, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 12, 1998
Comparative pharmacokinetics of oral and intravenous ifosfamide/mesna/methylene blue therapy
C Aeschlimann, A Küpfer, H Schefer, et al.
Palliative Medicine
|
March 9, 2007
Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods study
F Strasser, J Binswanger, T Cerny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2008
Remission of diabetes while on sunitinib treatment for renal cell carcinoma
A Templeton, M Brändle, T Cerny, et al.
Schweizerische Medizinische Wochenschrift
|
March 18, 1995
[Diagnosis and therapy of multiple myeloma: current aspects]
D C Betticher, T Cerny, M F Fey
Current Drug Targets
|
October 21, 2009
The role of pemetrexed in advanced non small-cell lung cancer: special focus on pharmacology and mechanism of action
M Joerger, A Omlin, T Cerny, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1991
Metabolism and pharmacokinetics of oral and intravenous ifosfamide
V Kurowski, T Cerny, A Küpfer, et al.
Seminars in Oncology
|
February 1, 1992
Novel approaches with ifosfamide in small cell lung cancer
N Thatcher, M Lind, E De Campos, et al.
Schweizerische Medizinische Wochenschrift
|
September 15, 1990
[Preventive and therapeutic measures in cytostatic-associated toxicity]
T Cerny, K Buser, J Kiser, et al.
British Journal of Cancer
|
April 1, 1986
Genetic predisposition to human lung cancer
J Heighway, N Thatcher, T Cerny, et al.
Page
of 15